Literature DB >> 5061055

Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration.

L Lemberger, J L Weiss, A M Watanabe, I M Galanter, R J Wyatt, P V Cardon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061055     DOI: 10.1056/NEJM197203302861303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

Authors:  Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; William D Darwin; Robert S Goodwin; Deanna L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-06-08       Impact factor: 8.327

2.  Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.

Authors:  Garry Milman; David M Schwope; Eugene W Schwilke; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-29       Impact factor: 8.327

3.  [Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].

Authors:  W Seeling; L Kneer; B Büchele; J E Gschwend; L Maier; C Nett; T Simmet; P Steffen; M Schneider; M Rockemann
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

4.  A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.

Authors:  L Cinnamon Bidwell; Hollis C Karoly; Marco Ortiz Torres; Ashley Master; Angela D Bryan; Kent E Hutchison
Journal:  Psychopharmacology (Berl)       Date:  2021-10-27       Impact factor: 4.530

Review 5.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.

Authors:  L Lemberger; R Martz; B Rodda; R Forney; H Rowe
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Smoking, vaping, eating: Is legalization impacting the way people use cannabis?

Authors:  Jacob T Borodovsky; Benjamin S Crosier; Dustin C Lee; James D Sargent; Alan J Budney
Journal:  Int J Drug Policy       Date:  2016-03-02

8.  Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.

Authors:  Garry Milman; Mateus M Bergamaschi; Dayong Lee; Damodara R Mendu; Allan J Barnes; Ryan Vandrey; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2014-04       Impact factor: 3.681

9.  Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man.

Authors:  D M Cocchetto; S M Owens; M Perez-Reyes; S DiGuiseppi; L L Miller
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 10.  Medical marijuana and driving: a review.

Authors:  Mark J Neavyn; Eike Blohm; Kavita M Babu; Steven B Bird
Journal:  J Med Toxicol       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.